243 related articles for article (PubMed ID: 33730996)
1. Triazoloacridone C-1305 impairs XBP1 splicing by acting as a potential IRE1α endoribonuclease inhibitor.
Bartoszewska S; Króliczewski J; Crossman DK; Pogorzelska A; Bagiński M; Collawn JF; Bartoszewski R
Cell Mol Biol Lett; 2021 Mar; 26(1):11. PubMed ID: 33730996
[TBL] [Abstract][Full Text] [Related]
2. Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.
Mimura N; Fulciniti M; Gorgun G; Tai YT; Cirstea D; Santo L; Hu Y; Fabre C; Minami J; Ohguchi H; Kiziltepe T; Ikeda H; Kawano Y; French M; Blumenthal M; Tam V; Kertesz NL; Malyankar UM; Hokenson M; Pham T; Zeng Q; Patterson JB; Richardson PG; Munshi NC; Anderson KC
Blood; 2012 Jun; 119(24):5772-81. PubMed ID: 22538852
[TBL] [Abstract][Full Text] [Related]
3. ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras.
Blazanin N; Son J; Craig-Lucas AB; John CL; Breech KJ; Podolsky MA; Glick AB
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9900-9905. PubMed ID: 28847931
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide mRNA profiling identifies X-box-binding protein 1 (XBP1) as an IRE1 and PUMA repressor.
Gebert M; Sobolewska A; Bartoszewska S; Cabaj A; Crossman DK; Króliczewski J; Madanecki P; Dąbrowski M; Collawn JF; Bartoszewski R
Cell Mol Life Sci; 2021 Nov; 78(21-22):7061-7080. PubMed ID: 34636989
[TBL] [Abstract][Full Text] [Related]
5. Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors.
Wang L; Perera BG; Hari SB; Bhhatarai B; Backes BJ; Seeliger MA; Schürer SC; Oakes SA; Papa FR; Maly DJ
Nat Chem Biol; 2012 Dec; 8(12):982-9. PubMed ID: 23086298
[TBL] [Abstract][Full Text] [Related]
6. Opposite Roles of RNase and Kinase Activities of Inositol-Requiring Enzyme 1 (IRE1) on HSV-1 Replication.
Su A; Wang H; Li Y; Wang X; Chen D; Wu Z
Viruses; 2017 Aug; 9(9):. PubMed ID: 28832521
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic IRE1alpha-mediated XBP1 mRNA splicing in the absence of nuclear processing and endoplasmic reticulum stress.
Back SH; Lee K; Vink E; Kaufman RJ
J Biol Chem; 2006 Jul; 281(27):18691-706. PubMed ID: 16644724
[TBL] [Abstract][Full Text] [Related]
8. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
Harnoss JM; Le Thomas A; Reichelt M; Guttman O; Wu TD; Marsters SA; Shemorry A; Lawrence DA; Kan D; Segal E; Merchant M; Totpal K; Crocker LM; Mesh K; Dohse M; Solon M; Modrusan Z; Rudolph J; Koeppen H; Walter P; Ashkenazi A
Cancer Res; 2020 Jun; 80(11):2368-2379. PubMed ID: 32265225
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
[TBL] [Abstract][Full Text] [Related]
10. ATF6 upregulates XBP1S and inhibits ER stress-mediated apoptosis in osteoarthritis cartilage.
Guo FJ; Xiong Z; Lu X; Ye M; Han X; Jiang R
Cell Signal; 2014 Feb; 26(2):332-42. PubMed ID: 24269637
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells.
Nguyen LC; Renner DM; Silva D; Yang D; Parenti NA; Medina KM; Nicolaescu V; Gula H; Drayman N; Valdespino A; Mohamed A; Dann C; Wannemo K; Robinson-Mailman L; Gonzalez A; Stock L; Cao M; Qiao Z; Moellering RE; Tay S; Randall G; Beers MF; Rosner MR; Oakes SA; Weiss SR
mBio; 2022 Oct; 13(5):e0241522. PubMed ID: 36125275
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.
Merlot AM; Shafie NH; Yu Y; Richardson V; Jansson PJ; Sahni S; Lane DJR; Kovacevic Z; Kalinowski DS; Richardson DR
Biochem Pharmacol; 2016 Jun; 109():27-47. PubMed ID: 27059255
[TBL] [Abstract][Full Text] [Related]
13. 4μ8C Inhibits Insulin Secretion Independent of IRE1α RNase Activity.
Sato H; Shiba Y; Tsuchiya Y; Saito M; Kohno K
Cell Struct Funct; 2017 May; 42(1):61-70. PubMed ID: 28321016
[TBL] [Abstract][Full Text] [Related]
14. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer.
Lin J; Liu H; Fukumoto T; Zundell J; Yan Q; Tang CA; Wu S; Zhou W; Guo D; Karakashev S; Hu CA; Sarma K; Kossenkov AV; Zhang R
Nat Commun; 2021 Sep; 12(1):5321. PubMed ID: 34493732
[TBL] [Abstract][Full Text] [Related]
15. XBP1-FoxO1 interaction regulates ER stress-induced autophagy in auditory cells.
Kishino A; Hayashi K; Hidai C; Masuda T; Nomura Y; Oshima T
Sci Rep; 2017 Jun; 7(1):4442. PubMed ID: 28667325
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanism of enhancing IRE1α-XBP1 signalling via the PERK-ATF4 pathway.
Tsuru A; Imai Y; Saito M; Kohno K
Sci Rep; 2016 Apr; 6():24217. PubMed ID: 27052593
[TBL] [Abstract][Full Text] [Related]
17. Mammalian IRE1α dynamically and functionally coalesces with stress granules.
Liu S; Zhang X; Yao X; Wang G; Huang S; Chen P; Tang M; Cai J; Wu Z; Zhang Y; Xu R; Liu K; He K; Wang Y; Jiang L; Wang QA; Rui L; Liu J; Liu Y
Nat Cell Biol; 2024 Jun; 26(6):917-931. PubMed ID: 38714852
[TBL] [Abstract][Full Text] [Related]
18. IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling.
Chen C; Zhang X
J Transl Med; 2017 Feb; 15(1):42. PubMed ID: 28222747
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells.
Wang FM; Galson DL; Roodman GD; Ouyang H
Exp Hematol; 2011 Oct; 39(10):999-1006. PubMed ID: 21723843
[TBL] [Abstract][Full Text] [Related]
20. IRE1α Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8
Medel B; Costoya C; Fernandez D; Pereda C; Lladser A; Sauma D; Pacheco R; Iwawaki T; Salazar-Onfray F; Osorio F
Front Immunol; 2018; 9():3050. PubMed ID: 30687308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
